Increased DOI-induced wet-dog shakes in adrenocorticotropic hormone-treated rats are not affected by chronic imipramine treatment: Possible involvement of enhanced 5-HT2A-receptor expression in the frontal cortex

Journal of Pharmacological Sciences

Volumn 106, Issue 1, 2008, Pages 100-106

  Kitamura, Yoshihisa ^a   Shibata, Kazuhiko ^c   Akiyama, Kozue ^c   Kimoto, Shizue ^c   Fujitani, Yoshika ^c   Kitagawa, Kouhei ^a,c   Kanzaki, Hirotaka ^b   Ouchida, Mamoru ^b   Shimizu, Kenji ^b   Kawasaki, Hiromu ^b   Sendo, Toshiaki ^c   Gomita, Yutaka ^c  

^a OKAYAMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

5 HT2A receptor; Adrenocorticotropic hormone; Receptor binding; Receptor mRNA; Wet dog shake

Indexed keywords

4 IODO 2,5 DIMETHOXYAMPHETAMINE; 5 HYDROXYINDOLEACETIC ACID; CORTICOTROPIN; IMIPRAMINE; KETANSERIN; MESSENGER RNA; SEROTONIN 2 RECEPTOR; SEROTONIN 2A RECEPTOR; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG EFFECT; DRUG RECEPTOR BINDING; DRUG RESEARCH; FRONTAL CORTEX; GENETIC TRANSCRIPTION; MALE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RAT; RECEPTOR BINDING; WET DOG SHAKES;

EID: 38549151080     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FP0071615     Document Type: Article

References (23)

1. Arango V, Ernsberger P, Marzuk PM, Chen JS, Tierney H, Stanley M, et al. Autoradiographic demonstration of increased serotonin 5-HT2 and β-adrenergic receptor binding sites in the brain of suicide victims. Arch Gen Psychiatry. 1990;47:1038-1047.
2. Arora RC, Meltzer HY. Serotonergic measures in the brains of suicide victims: 5-HT2 binding sites in the frontal cortex of suicide victims and control subjects. Am J Psychiatry. 1989;146:730-736.
3. 2 receptor binding on blood platelets-a perioheral marker for depression? Life Sci. 1987;41:2485-2492.
4. Mann JJ, Stanley M, McBride PA, McEwen BS. Increased serotonin2 and β-adrenergic receptor binding in the frontal cortices of suicide victims. Arch Gen Psychiatry. 1986;43:954-959.
5. 2A receptors in the postmortem brains of teenage suicide victims. Am J Psychiatry. 2002;159:419-429.
6. Carroll BJ, Curtis GC, Merdels J. Neuroendocrine regulation in depression: 1. Limbic system - adrenocortical dysfunction. Arch Gen Psychiatry. 1976;33:1039-1044.
7. Christie JE, Whalley LJ, Dick H, Blackwood DH, Blackburn IM, Fink G. Raised plasma cortical concentrations a feature of drug free psychotics and not specific for depression. Br J Psychiatry. 1986;148:58-65.
8. 2 receptor binding and on the receptor-mediated behavioral response of rats. Eur J Pharmacol. 1997;333:123-128.
9. 2A receptors in ACTH-treated rats. Pharmacol Biochem Behav. 2005;81:65-70.
10. 2A receptor in ACTH-treated rats. Pharmacol Biochem Behav. 2002;72:397-402.
11. 1A receptors in the DOI-induced wet-dog shakes in ACTH-treated rats. Biol Pharm Bull. 2007;30:117-120.
12. Peroutka SJ, Snyder SH. Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding. Science. 1980;210:88-90.
13. 3 receptors in the activity of antidepressants in the mouse forced swimming test. Eur J Pharmacol. 1997;325:129-135.
14. 2A receptors in depression. J Psychiatry Neurosci. 2004;29:252-265.
15. Kitamura Y, Araki H, Gomita Y. Influence of ACTH on the effects of imipramine, desipramine and lithium on duration of immobility of rats in the forced swim test. Pharmacol Biochem Behav. 2002;71:63-69.
16. Kitamura Y, Akiyama K, Hashimoto S, Kitagawa K, Kawasaki H, Shibata K, et al. Effects of imipramine on extracellular serotonin and noradrenaline concentrations in ACTH-treated rats. Eur J Pharmacol. 2007;566:113-116.
17. Garlow SJ, Ciaranello RD. Transcriptional control of the rats serotonin-2 receptor gene. Brain Res, Mol Brain Res. 1995;31:201-209.
18. Mochizuki D, Tsujita R, Yamada S, Kawasaki K, Otsuka Y, Hashimoto S, et al. Neurochemical and behavioral characterization of milnacipran, a serotonin and noradrenaline reuptake inhibitor in rats. Psychopharmacology. 2002;162:323-332.
19. De Barioglio SR, Lezcano N, Celis ME. Alpha MSH-induced excessive grooming behavior involves a GABAergic mechanism. Peptides. 1991;12:203-205.
20. Von Frijtag JC, Croiset G, Gispen WH, Adan RAH, Wiegant VM. The role of central melanocortin receptors in the activation of the hypothalamus-pituitary- adrenal-axis and the induction of excessive grooming. Br J Pharmacol. 1998;123:1053-1058.
21. Lu XY, Barsh GS, Akil H, Watson SJ. Interaction between - melanocyte-stimulating hormone and corticotrophin-releasing hormone in the regulation of feeding and hypothalamo-pituitary-adrenal responses. J Neurosci. 2003;23:7863-7872.
22. Chaki S, Hirota S, Funakoshi T, Suzuki Y, Suetake S, Okubo T, et al. Anxiolytic-like and antidepressant-like activities of MCL0129 (1-[(S)-2-(4-fluorophenyl)-2-(4-isopropylpiperadin-1-yl)ethyl] -4-[4-(2-methoxynaphthalen-1-yl)butyl]piperazine), a novel and potent nonpeptide antagonist of the melanocortin-4 receptor. J Pharmacol Exp Ther. 2003;304:818-826.
23. Kawashima N, Chaki S, Okuyama S. Electrophysiological effects of melanocortin receptor ligands on neuronal activities of monoaminergic neurons in rats. Neurosci Lett. 2003,353:119-122.